SF Q1 2026 Earnings EPS Slightly Exceeds Estimates Shares Dip ConocoPhillips COP Q1 2026 Earnings EPS Beats Estimates by 1323 as Operational Efficiency Drives Profitability Stock Slips Slightly Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 IMCR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Pipeline Progress CMSD Q1 2026 Earnings Utility Core Earnings Beat Estimate Shares Edge Higher IIIN Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises